Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), ratio decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), ratio decreased (Expand Search)
-
3761
-
3762
-
3763
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
3764
-
3765
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
3766
-
3767
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
3768
-
3769
-
3770
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
3771
-
3772
-
3773
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
3774
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
3775
-
3776
-
3777
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
3778
-
3779
-
3780